Proteins and Peptides
1 July 2013
Halozyme Presents New HTI-501 Data24 June 2013
Follow-up Phase II Data Analysis Adds to Body of Evidence for Investigational Novel Basal Insulin, LY260554124 June 2013
RegeneRx Releases Results of Phase 2 Clinical Trial on Patients with Epidermolysis Bullosa24 June 2013
Biogen Idec Showcases Commitment to Advancing Hemophilia Treatment and Care at ISTH Congress21 June 2013
FDA grants Breakthrough Therapy designation to Novartis’ serelaxin (RLX030) for acute heart failureNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports